Harleen Grewal

Harleen Grewal practices at Henry Mayo Newhall Hospital in Valencia, California, part of Henry Mayo Newhall Hospital.

Harleen Grewal's NPI, 1124551593, was assigned on April 4, 2017. Harleen Grewal graduated from WashU Medicine in 2017. Harleen Grewal holds California license A157685.

Harleen Grewal's primary practice is Henry Mayo Newhall Hospital, at 23845 McBean Pkwy, Valencia, CA 91355 in Los Angeles County. The practice phone is (661) 253-8000.

Harleen Grewal's primary practice is Henry Mayo Newhall Hospital in Valencia, California, part of Henry Mayo Newhall Hospital. The medical group on file is Southern California Permanente Medical Group. Dmand AI also links Harleen Grewal to 7 more group practices and clinics and 7 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Harleen Grewal practices, 8 sites in all. Vendor and product names are available with a free account.

Emergency medicine is Harleen Grewal's primary specialty in the NPI Registry, under taxonomy code 207P00000X. Harleen Grewal is board certified in emergency medicine by the American Board of Emergency Medicine. Harleen Grewal is licensed in California.

CMS data shows 424 Medicare services from Harleen Grewal across 4 procedure codes in 2024, for 319 Medicare patients. Medicare paid $42,951 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 319 Medicare patients who saw Harleen Grewal in 2024. The largest group is 75 to 84, with 113 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 39% are also on Medicaid. Their average risk score is 2.20, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Harleen Grewal's median patient age at 48, with 59% women.

In 2024, Harleen Grewal wrote 186 Medicare Part D claims for 133 patients. 96% of them were for generic drugs. CMS names the drug for 88 of them, across 5 drugs with 11 or more claims each, at $534 in total drug cost. In 2023, CMS named 112 claims across 7 drugs.

Dmand AI links 4 papers to Harleen Grewal, published from 2010 to 2022. The most frequent topics are Tuberculosis, Pulmonary.

CMS Open Payments shows 4 general payments to Harleen Grewal from 3 drug and device companies from 2023 to 2025. Food and beverage make up the largest share, 100% of the total. Merz North America, Inc. paid the most, $100.

Harleen Grewal graduated from WashU Medicine in 2017.

Harleen Grewal is in network with 8 carriers, including United Healthcare, Elevance and Alliant Health Plans. HMO plans come from the most carriers, 3. Check the plan with the practice before a visit.